What’s new with DiaSorin Molecular.

Available here is a selection of our latest news about DiaSorin Molecular.
Filter by year
Published on 10 Jul 2017

DiaSorin Molecular launches IAM CBFB-MYH11, completing the diagnostic test menu for molecular screening of acute myeloid leukemia by Q-LAMP.

DiaSorin Molecular launches a new CE-IVD molecular diagnostic test, Iam CBFB-MYH11 (not available in the USA) for the ultra-rapid identification of one of the most common genetic causes of Acute Myeloid Leukemia (AML). This new early diagnosis will aid effective stratification of patient risk, facilitating timely and effective implementation of therapy for patient management improvement.

DiaSorin Molecular Admin